Novel PET imaging approach detects heart damage in patients with non-ischemic cardiomyopathy Peer-Reviewed Publication Society of Nuclear Medicine and Molecular Imaging image: Figure 1.

BACKGROUND: Dilated cardiomyopathy (DCM) appears to be diagnosed twice as often in male than in female patients. This could be attributed to underdiagnosis in female patients or sex differences in ...

Fifty patients with various types of non-ischemic cardiomyopathy underwent ⁶⁸Ga-FAPI PET/CT scans to measure heart fibroblast activity.

This study is on patients with severe multivessel disease and ischemic cardiomyopathy. Do they have significant improvement in their LV function after local delivery of autologous skeletal myoblasts?

Hemostemix Inc. Begins Commercial Offering of ACP-01 (VesCell) for Ischemic Pain Treatments in Florida. Calgary, ...

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") announces that the TSX Venture ...

Regitz, V. & Fleck, E. Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am.

Aim The aim of this study was to characterize an alternative treatment for dilated cardiomyopathy (DCM) using a novel cardiac biological assist device created from engineered heart tissue (EHT ...

June 26, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") announces its Chairman, Peter Lacey, has provided the Company with a lead order for a non ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...